163 related articles for article (PubMed ID: 35389581)
1. Pustular and Erythrodermic Psoriasis in Patients Treated With Oral Glucocorticoids: A Survey of United States Dermatologists.
Awh K; Albornoz C; Nadhan K; Buckley M; Feldman S; Albornoz MA
J Drugs Dermatol; 2022 Apr; 21(4):427-429. PubMed ID: 35389581
[TBL] [Abstract][Full Text] [Related]
2. Approach to the Epidemiology, Disease Management, and Current Challenges in the Management of Generalized Pustular Psoriasis Through a Survey Conducted Among Spanish Dermatologists.
Vilarrasa E; Rivera R; Eiris N; Carretero G; de la Cueva P; Carrascosa JM
Actas Dermosifiliogr; 2024 May; 115(5):449-457. PubMed ID: 37925068
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of risankizumab in Japanese patients with generalized pustular psoriasis or erythrodermic psoriasis: Primary analysis and 180-week follow-up results from the phase 3, multicenter IMMspire study.
Yamanaka K; Okubo Y; Yasuda I; Saito N; Messina I; Morita A
J Dermatol; 2023 Feb; 50(2):195-202. PubMed ID: 36514850
[TBL] [Abstract][Full Text] [Related]
4. Ixekizumab 80 mg Every 2 Weeks Treatment Beyond Week 12 for Japanese Patients with Generalized Pustular Psoriasis and Erythrodermic Psoriasis.
Morita A; Okubo Y; Morisaki Y; Torisu-Itakura H; Umezawa Y
Dermatol Ther (Heidelb); 2022 Feb; 12(2):481-494. PubMed ID: 34967916
[TBL] [Abstract][Full Text] [Related]
5. Unmet Medical Needs in the Treatment and Management of Generalized Pustular Psoriasis Flares: Evidence from a Survey of Corrona Registry Dermatologists.
Strober B; Kotowsky N; Medeiros R; Mackey RH; Harrold LR; Valdecantos WC; Flack M; Golembesky AK; Lebwohl M
Dermatol Ther (Heidelb); 2021 Apr; 11(2):529-541. PubMed ID: 33638115
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and Safety of Certolizumab Pegol in Japanese Patients with Generalized Pustular Psoriasis and Erythrodermic Psoriasis: 52-Week Results.
Okubo Y; Umezawa Y; Sakurai S; Hoshii N; Nakagawa H
Dermatol Ther (Heidelb); 2022 Jun; 12(6):1397-1415. PubMed ID: 35622315
[TBL] [Abstract][Full Text] [Related]
7. Guselkumab, a human interleukin-23 monoclonal antibody in Japanese patients with generalized pustular psoriasis and erythrodermic psoriasis: Efficacy and safety analyses of a 52-week, phase 3, multicenter, open-label study.
Sano S; Kubo H; Morishima H; Goto R; Zheng R; Nakagawa H
J Dermatol; 2018 May; 45(5):529-539. PubMed ID: 29569397
[TBL] [Abstract][Full Text] [Related]
8. Pustular Psoriasis: A Narrative Review of Recent Developments in Pathophysiology and Therapeutic Options.
Menter A; Van Voorhees AS; Hsu S
Dermatol Ther (Heidelb); 2021 Dec; 11(6):1917-1929. PubMed ID: 34626330
[TBL] [Abstract][Full Text] [Related]
9. Dermatologists' Perspectives on Defining Moderate Psoriasis: The Canadian Moderate Psoriasis Survey.
Gooderham M; Papp K; Albrecht L; Grewal P; Gaudreau AJ
J Drugs Dermatol; 2021 Feb; 20(2):126-132. PubMed ID: 33538558
[TBL] [Abstract][Full Text] [Related]
10. Treatment of Erythrodermic Psoriasis in Children with Secukinumab: A Case Report.
Lu X; Wang W
Clin Cosmet Investig Dermatol; 2023; 16():1977-1981. PubMed ID: 37539023
[TBL] [Abstract][Full Text] [Related]
11. Economic burden of generalized pustular psoriasis and palmoplantar pustulosis in the United States.
Hanna ML; Singer D; Valdecantos WC
Curr Med Res Opin; 2021 May; 37(5):735-742. PubMed ID: 33622113
[TBL] [Abstract][Full Text] [Related]
12. Higher prevalence of thyroid dysfunction in patients with erythrodermic psoriasis.
Zheng J; Gao Y; Liu N; Li Y; Chen F; Yu N; Ding Y; Yi X
J Dermatol; 2020 Sep; 47(9):1007-1012. PubMed ID: 32572971
[TBL] [Abstract][Full Text] [Related]
13. Regional differences in the prevalence of generalized pustular psoriasis in Japan.
Fujita H; Iwasaki R; Tsuboi S; Murashiuma Y; Akiyama M
J Dermatol; 2024 Mar; 51(3):380-390. PubMed ID: 38292005
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of open-label ixekizumab treatment in Japanese patients with moderate-to-severe plaque psoriasis, erythrodermic psoriasis and generalized pustular psoriasis.
Saeki H; Nakagawa H; Ishii T; Morisaki Y; Aoki T; Berclaz PY; Heffernan M
J Eur Acad Dermatol Venereol; 2015 Jun; 29(6):1148-55. PubMed ID: 25355284
[TBL] [Abstract][Full Text] [Related]
15. Long-term efficacy and safety of ixekizumab in Japanese patients with erythrodermic or generalized pustular psoriasis: subgroup analyses of an open-label, phase 3 study (UNCOVER-J).
Okubo Y; Mabuchi T; Iwatsuki K; Elmaraghy H; Torisu-Itakura H; Morisaki Y; Nakajo K
J Eur Acad Dermatol Venereol; 2019 Feb; 33(2):325-332. PubMed ID: 30317671
[TBL] [Abstract][Full Text] [Related]
16. Generalized pustular psoriasis: A global Delphi consensus on clinical course, diagnosis, treatment goals and disease management.
Puig L; Choon SE; Gottlieb AB; Marrakchi S; Prinz JC; Romiti R; Tada Y; von Bredow D; Gooderham M
J Eur Acad Dermatol Venereol; 2023 Apr; 37(4):737-752. PubMed ID: 36606566
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of hospitalizations and emergency department visits due to generalized pustular psoriasis in the United States.
Hanna ML; Singer D; Bender SD; Valdecantos WC; Wu JJ
Curr Med Res Opin; 2021 Oct; 37(10):1697-1703. PubMed ID: 34289766
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a Case Series of Patients With Generalized Pustular Psoriasis in the United States.
Noe MH; Wan MT; Mostaghimi A; Gelfand JM; ; Agnihothri R; Armstrong AW; Bhutani T; Bridges A; Brownstone N; Butt M; Duffin KPC; Carr C; Creadore A; DeNiro KL; Desai S; Dominguez AR; Duffy EK; Fairley JA; Femia A; Gudjonsson JE; Kaffenberger JA; Katz KL; Le ST; Martinez E; Maverakis E; Myers B; Naik HB; Nelson CA; Ortega-Loayza AG; Plovanich ME; Rangel LK; Ravi V; Reddy VD; Saleh JZ; Kirby JS; Sandhu JK; Shakshouk H; Shields BE; Sharif-Sidi Z; Smith J; Steahr A; Toussi A; Wanat KA; Wang B; Wei BM; Weinhammer A; Worswick SD; Yang A
JAMA Dermatol; 2022 Jan; 158(1):73-78. PubMed ID: 34878491
[TBL] [Abstract][Full Text] [Related]
19. Generalized pustular psoriasis - a model disease for specific targeted immunotherapy, systematic review.
Boehner A; Navarini AA; Eyerich K
Exp Dermatol; 2018 Oct; 27(10):1067-1077. PubMed ID: 29852521
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-19 and Generalised Pustular Psoriasis: A Lethal Combination.
Narang T; Sharma A; Bhandari A; Handa S; Dogra S
Indian J Dermatol; 2023; 68(6):726. PubMed ID: 38371580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
